RA Capital Nexus Fund, L.P. Sells Shares of Vor Biopharma Inc.

RA Capital Nexus Fund, L.P., a significant stockholder and director of Vor Biopharma Inc., has filed a Form 144 with the SEC indicating the sale of 42,816 common shares of Vor Biopharma Inc. The shares were sold on October 15 and 16, 2025, with gross proceeds totaling $981,644.35. The shares were originally acquired through private financing transactions in 2020 and 2021. The sale was executed through BTIG, LLC, and the aggregate market value of the shares sold is approximately $1,241,664. RA Capital Nexus Fund, L.P. continues to hold 6,841,134 common shares of Vor Biopharma Inc. This filing highlights the ongoing financial activities of a major investor in Vor Biopharma Inc.